TABLE 3.
Effects of THC and other cannabinoids on immune functions in vivo and in vitro
| Mode of administration and model | Immune functiona | Reference(s) |
|---|---|---|
| In vivo | ||
| Humans | ↓Lymphoproliferation | 154 |
| ↓Antimicrobial activity | 14 | |
| ↓Cytokine production | 14 | |
| Mice | ↓↑Serum Ig levels | 155 |
| ↓Cellular immunity | 112, 163, 214 | |
| ↓Antimicrobial activity | 8, 34, 147, 222 | |
| ↓Humoral immunity | 10, 102, 198 | |
| ↑Apoptosis | 140 | |
| ↓↑Cell signaling | 50, 241 | |
| In vitro | ||
| Humans | ↓Lymphocyte proliferation | 153, 221 |
| ↓NK cell activity | 219, 220 | |
| ↓Neutrophil antifungal activity | 55 | |
| ↑↓Cytokine production | 223, 255 | |
| Mice | ↓Lymphocyte proliferation | 113, 140, 181, 182 |
| ↓NK cell activity | 104, 110, 133 | |
| ↓Antibody formation | 9, 107 | |
| ↓↑IL-2 system receptors | 46, 79, 270, 271 | |
| ↓↑Cytokine production | 14, 108, 162 | |
| ↑Apoptosis | 140, 269 | |
| ↓↑Cell signaling | 46, 62, 79 |
↑, increase; ↓, decrease; ↑↓, both increase and decrease.